Probicobacter tablete s Pylopass^TM, ki se veže s Helicobacter pylori in prispeva k njenemu izločanju iz telesa.

Z dodatkom ekstrakta brokolija ter z vitamini A, C, B12 in cinkom.

Kako se Probicobacter tablete s Pylopass^TM oprimejo Helicobacter pylori?

• Pylopass^TM vsebuje površinske strukture z molekulami, ki prepoznajo in se oprimejo površine Helicobacter pylori.
• Po vezavi se novo nastali ko-agregat (Pylopass^TM + H. pylori)  z odvajanjem blata izloči iz telesa. Pylopass^TM se veže specifično le s H.pylori in ne spremeni črevesne mikroflore.

Rezultati kliničnih študij Pylopass^TM:

• Po 14 dneh zmanjša obremenitev s H. pylori,
• Prispeva k večji učinkovitosti anti- H. pylori terapije,
• Prispeva k zmanjšanju simptomov nelagodja v želodcu.

Prednosti Probicobacter tablet Soria natural z Lactobacilus reuteri PylopassTM:

• Stabilnost pri sobni temperaturi najmanj 2 leti. Shranjevanje v hladilniku ni potrebno.
• Deluje specifično na H.pylori in ne vpliva na nobeno drugo bakterijo v črevesju.
• Stabilnost v kislem okolju želodca.
• Dobra toleranca, brez neželenih učinkov.

Viri:

Lactobacillus reuteri PylopassTM

⦁ Mehling H, Busjahn A, Non-viable Lactobacillus reuteri DSMZ 17648 (Pylopass™) as a new approach to Helicobacter pylori control in humans. Nutrients. 2013 Aug 2;5 (8):3062-73. doi: 10.3390/nu5083062.

⦁ Holz C, Busjahn A, Mehling H, Arja S, Boettner M, Habibi H, Land C. Significant Reduction in Helicobacter pylori Load in Humans with Non-viable Lactobacillus reuteri DSM17648: A Pilot Study. ⦁ Probiotics Antimicrob Proteins. 2015 Jun; 7(2):91-100 doi: ⦁ 10.1007/s12602-014-9181-3

⦁ Uspenskiy Yu.P, Fomin Yu. A, Ivanov S.V, Menaker I.O. Evolution in eradication therapy of HP -associated diseases: beyond the standards? Russian scientific publication in Gastroenterology No 17,2016

⦁ Parolova Ni, Komienko EA, Antonov PV, Egorov Mikhail Gorbunov EF, Dmitrienko MA. An innovative approach in the treatment of H. pylori infection in children.

⦁ Pop Muresan IA, Liviu Pop L, Dumitrascu DL, Lactobacillus reuteri versus triple therapy for the eradication of Helicobacter pylori in functional dyspepsia. Gastroenterology. 2019. DOI: 10.15386/mpr-1375.

⦁ Buckley et al. The effect of Lactobacillus reuteri supplementation in Helicobacter pylori infection: a placebo-controlled, single-blind study. BMC Nutrition (2018) 4:48 https://doi.org/10.1186/s40795-018-0257-4

Tong JL, ⦁ Ran ZH, ⦁ Shen J, ⦁ Zhang CX, ⦁ Xiao SD. Meta-analysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther. 2007 Jan 15;25(2):155-68.